Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Azienda Ospedaliero-Universitaria di Parma
Mayo Clinic
Incyte Corporation
Cedars-Sinai Medical Center
Universidade Federal de Pernambuco
Cyteir Therapeutics, Inc.
Cedars-Sinai Medical Center
OHSU Knight Cancer Institute
First Affiliated Hospital of Wenzhou Medical University
Shenzhen BinDeBio Ltd.
Leaf Vertical Inc.
Celgene
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
Rutgers, The State University of New Jersey
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
AstraZeneca